Featured Clinical Trial:

Chronic lymphocytic leukemia

ClinicAid Locations: Southern California – Fountain Valley, Corona, Riverside

Status:
Open for enrollment (accepting patients). Please contact us and mention Trial ID NCT01081015.

Condition: Chronic lymphocytic leukemia

Product Name/Compound: None - registry trial (What's a registry trial?)

Full Study Title: Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Study Summary: Explore the history and real world management of patients diagnosed with CLL, provide insight into the management of CLL, and evaluate the effectiveness of first, second and subsequent therapeutic strategies employed in both the community and academic settings

Eligible Participants:

Inclusion (Eligible):

• Clinical diagnosis with CLL
• Clinical decision made to initiate first-line therapy, second-line therapy or subsequent line of therapy prior to enrollment into the ConnectTM CLL registry, but within 2 months of enrollment
• Age ≥18 years
• Willing and able to complete patient assessment questionnaires either alone or with minimal assistance from caregivers and/or trained site personnel

Exclusion (Not Eligible):

• Participation in a clinical study in which study treatment is blinded
• Patient condition is considered terminal (i.e. < 6 months to live)

Study Phase: Phase IV (What are Phases?)

To receive information and updates for this trial:
Please contact us and mention the Trial ID below.

Trial ID (ClinicalTrials.gov): NCT01081015

<< Back to all ClinicAid clinical trials